The United States heart valve devices market is experiencing strong growth, chiefly driven by the increasing prevalence of valvular heart diseases, a growing aging population, and technological advancements in minimally invasive treatments. The U.S. market was valued at approximately USD 3.59 billion in 2024, and it is projected to expand at a compound annual growth rate (CAGR) of 9.60% from...